Comparative statistics by cancer registry

Table4: Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group

(Busan, South Korea, 1996-2001 cases followed-up until 2003)

Click on cancer site (ICD-10 code) for comparison

Site	ICD-10	No. of cases	Male			Female			Number of cases by age group					Relative survival by age group
			5-year survival			5-year survival			Number of cases by age group					Relative survival by age group
			No.	Abs	Rel	No.	Abs	Rel	<45	45-54	55-64	65-74	75+	<45	45-54	55-64	65-74	75+
C01-02	Tongue	144	97	41.6	45.9	47	57.7	61.5	28	27	57	23	9	55.7	72.8	41.5	44.7	48.1
C03-06	Oral cavity	156	108	34.3	38.7	48	55.4	59.3	26	23	47	43	17	85.4	42.5	54.4	15.4	28.6
C07-08	Salivary gland	86	48	59.2	63.9	38	76.6	79.6	31	13	24	14	4	88.9	94.9	53.9	47.6	0.0
C09	Tonsil	59	50	52.2	58.0	9	22.2	23.8	6	13	20	18	2	85.5	78.7	42.8	30.3	73.1
C10	Other oropharynx	34	30	22.0	25.3	4			2	7	13	10	2	0.0	29.7	25.4	25.3	0.0
C11	Nasopharynx	134	87	47.9	51.5	47	54.8	55.9	45	36	34	16	3	58.8	57.0	53.0	35.9	0.0
C12-13	Hypopharynx	87	80	14.6	17.1	7	24.5	24.8	5	18	34	21	9	20.2	53.5	0.0	14.6	0.0
C15	Oesophagus	790	706	15.4	17.5	84	22.9	26.0	23	130	310	240	87	22.1	28.5	18.8	14.4	9.9
C16	Stomach	8683	5637	40.7	45.3	3046	39.4	42.1	1348	1686	2701	2077	871	53.1	55.9	48.1	34.3	14.8
C17	Small intestine	141	91	13.0	14.9	50	30.9	32.3	18	27	43	38	15	53.4	9.4	27.5	13.7	10.4
C18	Colon	1859	1003	50.0	56.5	856	47.7	51.9	261	325	550	457	266	60.6	67.4	58.8	48.5	30.9
C19-20	Rectum	1882	1031	48.9	55.4	851	50.4	53.9	270	414	536	456	206	53.7	59.8	63.4	53.0	23.4
C21	Anus	60	27	46.2	54.5	33	45.5	49.0	7	9	15	17	12	43.2	101.7	54.0	54.4	0.0
C22	Liver	6507	4828	8.4	9.3	1679	9.6	10.4	797	1711	2096	1400	503	12.6	10.6	9.6	6.0	8.0
C23-24	Gall bladder	1524	714	14.6	16.5	810	14.6	16.0	79	223	440	509	273	32.3	29.3	18.9	10.2	5.4
C25	Pancreas	1011	600	4.3	5.1	411	7.2	8.0	71	154	328	308	150	17.8	5.2	6.7	4.4	4.9
C30-31	Nose/Sinuses	103	67	33.3	38.0	36	31.4	34.1	13	19	35	26	10	53.9	20.1	32.9	45.0	31.4
C32	Larynx	475	422	51.4	58.4	53	35.9	40.6	22	95	172	142	44	61.0	65.9	63.0	45.9	38.2
C33-34	Lung	4796	3518	9.9	11.3	1278	12.0	13.4	260	638	1537	1625	736	23.0	18.1	14.4	7.3	6.6
C37-38	Other thoracic organs	148	101	30.3	32.1	47	37.0	39.4	49	30	33	24	12	50.8	34.4	23.3	30.4	0.0
C40-41	Bone	196	108	57.2	59.1	88	46.2	47.8	123	21	27	17	8	68.5	43.0	38.1	17.8	0.0
C43	Melanoma skin	86	47	38.2	42.7	39	42.4	48.1	21	14	23	17	11	37.1	55.0	42.7	67.7	27.5
C44	Other skin	423	211	71.0	82.4	212	83.4	94.5	64	65	109	110	75	93.3	95.3	86.7	84.6	86.5
C45	Mesothelioma	30	15	20.0	21.7	15	11.4	11.7	6	7	8	8	1	16.7	29.6	27.1	0.0	0.0
C47+C49	Connective tissue	250	144	41.0	43.6	106	46.6	48.5	104	46	54	35	11	56.2	54.8	39.1	23.4	17.7
C50	Breast	2642	19	69.7	89.5	2623	79.7	81.6	1079	871	485	173	34	83.9	81.2	81.3	73.9	52.5
C51	Vulva	25				25	62.1	67.2	5	5	5	8	2	78.2	101.5	62.3	58.4	0.0
C53	Cervix	2264				2264	74.1	76.3	912	595	437	246	74	86.1	79.1	73.8	51.7	16.3
C54	Corpus uteri	265				265	76.0	78.3	76	87	72	28	2	91.1	79.5	71.0	61.0	0.0
C56	Ovary	622				622	56.0	57.7	239	137	128	85	33	78.8	60.2	42.8	26.2	27.0
C58	Placenta	30				30	86.3	86.8	24	6	0	0	0	87.5	84.4	0.0	0.0	0.0
C60	Penis	29	29	73.5	88.8				4	6	8	6	5	25.6	65.3	109.6	84.6	166.7
C61	Prostate	430	430	41.9	54.5				6	15	100	176	133	45.4	25.7	60.9	64.2	39.6
C62	Testis	55	55	74.0	74.9				49	3	3	0	0	78.5	34.6	0.0	0.0	0.0
C64	Kidney	706	477	55.1	60.2	229	60.9	64.5	141	162	221	145	37	77.3	69.9	54.8	57.6	15.7
C65	Renal pelvis	74	56	44.9	51.7	18	44.4	48.0	8	10	29	21	6	0.0	62.5	56.7	39.2	0.0
C66	Ureter	77	48	50.7	59.5	29	45.6	50.4	2	10	23	25	17	101.8	56.8	76.5	27.2	53.2
C67	Urinary bladder	999	800	60.8	70.4	199	56.4	64.0	89	152	304	290	164	81.9	89.1	74.4	60.4	46.2
C69	Eye	36	20	55.0	57.7	16	65.5	67.3	22	1	6	4	3	76.3	106.6	71.2	0.0	0.0
C70-72	Brain & nervous system	520	284	35.0	36.0	236	40.0	41.0	275	91	77	58	19	51.8	33.4	16.4	16.0	19.8
C73	Thyroid	1175	206	81.3	86.7	969	91.3	94.0	554	265	199	122	35	98.1	96.2	92.7	77.8	32.6
C74-75	Adrenal gland, other endocrine	56	36	45.0	45.6	20	64.4	65.6	41	5	6	4	0	63.5	20.3	17.9	29.7	0.0
C81	Hodgkin lymphoma	52	32	59.7	63.3	20	65.7	67.7	22	11	11	7	1	94.3	47.5	32.3	48.5	0.0
C82-85+C96	Non-Hodgkin lymphoma	785	440	42.4	45.8	345	44.3	46.7	245	147	200	135	58	56.9	47.3	48.9	27.5	27.3
C90	Multiple myeloma	182	100	10.3	11.4	82	12.3	13.3	10	35	68	58	11	27.6	18.3	15.5	5.7	0.0
C91	Lymphoid leukaemia	222	142	37.4	37.7	80	49.7	50.1	183	15	14	10	0	48.1	23.8	19.6	0.0	0.0
C92-94	Myeloid leukaemia	480	273	25.6	26.8	207	28.1	28.8	270	60	85	50	15	36.0	29.9	16.8	6.8	0.0
C95	Leukaemia unspecified	44	22	13.6	17.7	22			13	4	5	13	9	0.0	0.0	0.0	9.5	16.7

Graphs:

5-year absolute survival for male

5-year relative survival for male

5-year absolute survival for female

5-year relative survival for female

5-year relative survival by age group: -45

5-year relative survival by age group: 45-54

5-year relative survival by age group: 55-64

5-year relative survival by age group: 65-74

5-year relative survival by age group: +75

Other tables available for this registry:

- Table1:	Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site (Busan, South Korea, 1996-2001 cases followed-up until 2003)
- Table2b:	Number and proportion of cases by vital status and median follow-up (in months) by site (Busan, South Korea, 1996-2001 cases followed-up until 2003)
- Table3:	Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site (Busan, South Korea, 1996-2001 cases followed-up until 2003)
- Table4:	Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group (Busan, South Korea, 1996-2001 cases followed-up until 2003)

Registry chapter:

Consult the chapter in Cancer survival in developping countries (Volume II)

Cancer survival in Africa, Asia, the Caribbean and Central America (SurvCan)

Comparative statistics by cancer registry

Table4: Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group